http://www.terraeco.net/cannabis-pharmacie-vente-maladie,50238.html Nothing but good +ve news resulting in an illiquid stock with a sterile share price. This will change, but when? Yes I know, "GW anticipates that Top-Line results from two phase 3 trials will be available 2014." [Justin Gover - interim results 3rd June 2013]
Fancy a GW job! Choose from 4
http://www.jobsinkent.com/job/485468/head_of_clinical_trial_supplies.html : http://www.jobsinkent.com/job/485717/quality_system_project_lead.html : http://www.jobsinkent.com/job/485469/process_chemist_separations_and_extractions.html Interesting, GW are using the job centre attracting top talent.
http://www.investorideas.com/news/2013/biotech/06131.asp and a French web article which Google translate should make into your chosen language http://lci.tf1.fr/science/sante/le-premier-medicament-a-base-de-cannabis-sera-surement-un-spray-8017378.html
GWP will move to £/$ rate for ..
sp float on Nasdaq at around 47.5 p and $ was 1.55 ish so downtick at moment
12 Jun '13
France legalises cannabis
http://www.sbwire.com/press-releases/france-legalizes-medical-marijuana-use-263818.htm more good news!
10 Jun '13
RE: Welcome aboard Bluedealer
Thanks for the welcome, Wise_Oracle...I have seen several studies on the benefits' and it is about time this rather special "herb" was given the respect it is due :) I have nothing like the size of your holding but I will build up as my funds allow as I feel it will do very well in the longer term. Best regards, Blue
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.